0001209191-22-051141.txt : 20220923
0001209191-22-051141.hdr.sgml : 20220923
20220923162506
ACCESSION NUMBER: 0001209191-22-051141
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220921
FILED AS OF DATE: 20220923
DATE AS OF CHANGE: 20220923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JANNEY DANIEL
CENTRAL INDEX KEY: 0001198325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38582
FILM NUMBER: 221262630
MAIL ADDRESS:
STREET 1: PO BOX 7414
CITY: JACKSON
STATE: WY
ZIP: 83002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allakos Inc.
CENTRAL INDEX KEY: 0001564824
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454798831
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: SUITE 500
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-597-5002
MAIL ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: SUITE 500
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-21
0
0001564824
Allakos Inc.
ALLK
0001198325
JANNEY DANIEL
PO BOX 7414
JACKSON
WY
83002
1
0
1
0
Common Stock
2022-09-21
4
P
0
475000
5.02
A
2546147
I
By Alta Partners NextGen Fund I, L.P.
Common Stock
6448053
I
By Alta Partners VIII, L.P.
Common Stock
56293
I
By Alta Bioequities L.P.
Reports the purchase of shares in the underwritten public offering of common stock of the Issuer.
The shares are directly held by Alta Partners NextGen Fund I, L.P. ("APNG I"). Alta Partners NextGen Fund I Management, LLC ("APNG I Management") is the general partner of APNG I. The Reporting Person is one of three managing directors of APNG I Management and, as such, has voting and investment control with respect to the shares held by APNG I. The Reporting Person disclaims beneficial ownership of all shares held by APNG I, except to the extent of his pecuniary interest therein.
The shares are directly held by Alta Partners VIII, L.P. ("Alta VIII"). Alta Partners Management VIII, LLC ("Alta Management VIII") is the general partner of Alta VIII. The Reporting Person is a managing director of Alta Management VIII and, as such, may be deemed to share voting and investment control with respect to the shares held by Alta VIII. The Reporting Person disclaims beneficial ownership of all shares held by Alta VIII, except to the extent of his pecuniary interest therein.
Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. Daniel Janney is the Managing Director of Alta Bioequities Management, LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
/s/ Daniel Janney
2022-09-23